Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Mallinckrodt
Harvard Business School
McKesson
Johnson and Johnson

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Litigation Details for CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC. (D.N.J. 2018)


Email this page to a colleague

« Back to Dashboard

CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC. (D.N.J. 2018)

Docket ⤷  Try it Free Date Filed 2018-06-19
Court District Court, D. New Jersey Date Terminated 2019-05-13
Cause 15:1126 Patent Infringement Assigned To Esther Salas
Jury Demand None Referred To Michael A. Hammer
Parties SYNTHON B.V.
Patents 6,281,230; 6,476,052; 6,555,554; 7,393,862; 7,968,569; 8,198,262; 8,673,939; 8,735,428; 8,828,427; 9,993,467
Attorneys AARON SCOTT ECKENTHAL
Firms Saul Ewing Arnstein & Lehr LLP
Link to Docket External link to docket
Small Molecule Drugs cited in CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free and ⤷  Try it Free .
Biologic Drugs cited in CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC.
The biologic drugs covered by the patents cited in this case are ⤷  Try it Free and ⤷  Try it Free .

Details for CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-06-19 1 Complaint Corporation, Summit, NJ (US) 6,281,230 B1 8/2001 Muller eta!. … a patient in need of such treatment or pre- 6,281,230 and 6,316,471, both to G. W. Muller, eta!. … such as those described in U.S. Pat. Nos. 6,281,230 and proteins and antibodies), examples of which… Pat. Nos. 6,281,230; 6,316,471; 6,335,349; and 6,476,052, compounds…antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ External link to document
2018-11-19 24 Amended Complaint Corporation, Summit, NJ (US) 6,281,230 B1 8/2001 Muller eta!. …a patient in need of such treatment or pre- 6,281,230 and 6,316,471, both to G. W. Muller, eta!. … such as those described in U.S. Pat. Nos. 6,281,230 and proteins and antibodies), examples of which… Pat. Nos. 6,281,230; 6,316,471; 6,335,349; and 6,476,052, compounds…antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ External link to document
2019-05-09 50 Letter Consent Judgment, the term “Patents-in-Suit” shall mean U.S. Patent Nos. 8,198,262; 8,673,939; 8,735,428; … 4. Until expiration of the Patents-in-Suit, Synthon, including any of its successors…successors and assigns, is enjoined from infringing the Patents-in-Suit, on its own part or through any third …parties in connection with any infringement of the Patents-in-Suit by any such third parties in connection… 21 C.F.R. § 314.94(a)(12) with respect to the Patents-in-Suit. 9. Nothing herein External link to document
2019-05-13 52 Consent Judgment, the term “Patents-in-Suit” shall mean U.S. Patent Nos. 8.198,262; 8,673,939; 8.735.428: …10,093,648: and 10,093,649, 4. Until expiration of the Patents-in-Suit. Synthon, including any of its successors…successors and assigns, is enjoined from infringing the Patents-in-Suit, on its own part or through any third party…parties in connection with any infringement of the Patents-in-Suit by any such third parties in connection…21 C.F.R. §$ 314.94(a)(12) with respect to the Patents-in-Suit. 9, Nothing herein restricts or is intended External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Merck
Express Scripts
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.